Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: Results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial
Geller, Bram J., MD, Giugliano, Robert P., MD, SM, Braunwald, Eugene, MD, Murphy, Sabina A., MPH, Hanyok, James J., PharmD, Jin, Jianqing, PhD, Mercuri, Michele, MD, PhD, Antman, Elliott M., MD, Ruff, Christian T., MD, MPH
Published in The American heart journal (01.10.2015)
Published in The American heart journal (01.10.2015)
Get full text
Journal Article